[logo] HealthTree Foundation
more_vert
close
person Sign In / Create Account

Clinical Trials for High Risk Smoldering Myeloma Patients

Clinical Trials for High Risk Smoldering Myeloma Patients image

Clinical Trials for High Risk Smoldering Myeloma Patients

Webinar
event Jul 05, 2021 / 07:00PM - 08:00PM EDT
link icon facebook logo X logo linkedin logo reddit logo email icon

Event Description

Be proactive in your care by learning about what clinical trials are available to you. No matter where you are in the precursor journey, learning about these trials now can help prepare you for what might come in your future. Multiple Myeloma Specialist, Dr. Jeffrey Zonder, will share his experience in high-risk clinical trials and explain their importance in the future of myeloma. 

Schedule & Agenda

Event panelist Audrey Burton-Bethke
07:00 PM
Introductions
Audrey Burton-Bethke
Audrey welcomes everybody, shares the event agenda, and introduces our featured speaker.
Event panelist Jeffrey Zonder, M.D.
07:05 PM
Presentation
Jeffrey Zonder, M.D.
Dr. Zonder shares his experience in high-risk clinical trials and explains their importance in the future of myeloma. 
Event panelist Audience
07:35 PM
Q&A
Audience
Ask Dr. Zonder your questions about his presentation and clinical trials for high-risk smoldering myeloma patients.

Speakers & Moderators

The panelist Audrey Burton-Bethke
Audrey Burton-Bethke

Audrey joined the HealthTree Foundation as the Myeloma Community Program Director in 2020. While not knowing much about myeloma at the start, she has since worked hard to educate herself, empathize and learn from others' experiences. She loves this job. Audrey is passionate about serving others, loves learning, and enjoys a nice mug of hot chocolate no matter the weather.

Read Bio
The panelist Jeffrey Zonder, M.D.
Jeffrey Zonder, M.D.

Professor in the Departments of Oncology at the Barbara Ann Karmanos Cancer Institute (KCI) and Wayne State University School of Medicine. He is the leader of the KCI Multiple Myeloma and Amyloidosis Multidisciplinary Team and co-leader of Molecular Therapeutic Program. He is e member of the Steering Committee at the Multiple Myeloma Research Consortium, a medical advisor for the Amyloidosis Support Group Networks, and a member of the International Myeloma Working Group, the International Myeloma Society and the International Amyloidosis Society. He is a member of the Southwest Oncology Group’s (SWOG) Barlogie-Salmon Myeloma Committee. Dr. Zonder has authored or co-authored numerous original research papers, review articles, book chapters, and research abstracts on myeloma and amyloidosis. He completed a fellowship in hematology-oncology at Wayne State University and his medical residency at the University of Rochester, New York. He received his medical degree from Wayne State University School of Medicine.

Read Bio
HealthTree Connect Icon

Join the Conversation

This event is part of the Watch and Wait group in HealthTree Connect, a social media platform for people with blood cancer. If you want to connect with other patients and caregivers and talk about this topic, join HealthTree Connect.

Have Any Questions?

Thank you for your interest in the event. If you have any questions, we would love to help!

Feel free to give us a call or send us a message below.

support

Get In Touch With Us

phone

1-800-709-1113

email

Support@healthtree.org

Thanks to our sponsors:
Johnson and Johnson logo
Sanofi logo
Adaptive logo
Pfizer logo
GSK logo
Regeneron logo
All HealthTree resources available anywhere, anytime
Download our App
Download iOS App Download Android App
iphone app mockup
newsletter icon

Get the Latest Multiple Myeloma Updates, Delivered to You.

By subscribing to the HealthTree newsletter, you'll receive the latest research, treatment updates, and expert insights to help you navigate your health.